Symptoms and Underlying Pathology in the Diagnosis and Optimal Management of Atopic Dermatitis (AD): A 5-part Elsevier Learning Center.
Rheumatology
Improve your rheumatology knowledge by taking one of Elsevier's complimentary continuing medical education courses.
Symptoms and Underlying Pathology in the Diagnosis and Optimal Management of Atopic Dermatitis
Format: Webcast
Swollen Toe, Tip of the Iceberg–Assessing and Managing Hyperuricemia and Gout
Format: WebcastBoth hyperuricemia and gout are increasingly prevalent in the United States, though there are often deficits surrounding diagnosis, ongoing assessment and management. In two 15-minute discussions, listen as two experts discuss case-based examples of gout, providing clinicians with knowledge and increased competence for managing patients with gout.
Looking Beneath the Surface in Atopic Dermatitis: Targeting Immune Dysregulation and Delivering Comprehensive Care
Format: WebcastThis Interactive Exchange™ program will open with a brief 3D-animated video focused on the pathophysiologic underpinnings of atopic dermatitis. Expert faculty will then discuss best practices for comprehensive patient evaluations and the clinical profiles of systemic treatment options for patients with moderate-to-severe disease. With an overall goal of improving patient outcomes, this educational session has been designed to allow internationally recognized experts to translate the latest published evidence into actionable recommendations for individualized patient care.
Biosimilars in Rheumatoid Arthritis: Common Questions and Application to Practice
Format: WebcastBiologic agents that revolutionized the treatment of patients with rheumatoid arthritis (RA) are now being reformulated as biosimilar agents. However, many questions remain regarding biosimilars: "What are they?", "Are they truly interchangeable with their reference biologics?", and "What are the clinical and financial implications of biosimilars in the treatment of patients with RA?" This archived symposium activity will provide participants with the opportunity to identify key differences between biosimilars and their reference biologics, review policy guidelines for biosimilars including naming and considerations for interchangeability, and assess data on the efficacy, safety, and clinical implications of biosimilars as part of RA patient management.
Evolving Treatment Paradigms for Rheumatoid Arthritis: Translating Comprehensive Patient Evaluations Into Personalized Therapy
Format: Webcast SeriesWelcome to this RA CME Snapshot™ video series. Each 15-minute module offers focused, clinically actionable education for rheumatologists and other clinicians who manage patients with RA. For a comprehensive curriculum on current evidence-based guidelines and newly published data on the use of targeted inhibitors of interleukin (IL)-6 or Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathways, clinicians can complete all 6 video modules for a total of 1.5 AMA PRA Category 1 Credits™ or 1.5 hours of nursing contact hours.
A Better Look at Rheumatoid Arthritis: Using Imaging to Improve Patient Outcomes
Format: WebcastThis CME-accredited Point-of-Care 201™ program is intended for rheumatologists and other clinicians involved in the management of patients with rheumatoid arthritis (RA). During the video activity, two expert rheumatologists will translate the latest guidelines and clinical trial data into practical recommendations on the use of imaging modalities for the assessment of patients with RA. Topics will include reviews of various imaging techniques, use of ultrasonography to examine synovial inflammation and other changes in RA-affected joints, and application of imaging results to guide shared clinical decision-making with patients.
Clinical Issues in Rheumatoid Arthritis: Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs
Format: Live MeetingIn this Clinical Issues™ live symposium, an expert faculty panel will discuss and debate the latest insights into RA immunopathology with a focus on JAK enzyme activation, increase their understanding of treat-to-target recommendations and appropriate disease activity measures, and describe the mechanistic profiles and clinical trial data for current and emerging targeted synthetic DMARDs. Attendees will leave this engaging program with new information and a fresh perspective on the evolving best practices for managing patients with RA.
Clinical Advances in Rheumatoid Arthritis Resource Center
Format: Resource CenterThe Global Learning Center provides you with free access to the latest peer-reviewed clinical information related to the treatment of patients with rheumatoid arthritis (RA). The RA Global Learning Center is a freely accessible platform that aims to increase clinical knowledge by providing continuing medical educational (CME) activities, research articles, and other resources to healthcare providers who treat patients with RA.